Database Query Results : Parthenolide, ,

Part, Parthenolide: Click to Expand ⟱
Features:
Parthenolide is a naturally occurring sesquiterpene lactone derived from the medicinal plant feverfew (Tanacetum parthenium).
-Micheliolide (MCL) is converted readily from parthenolide (PTL), and has better stability and solubility than PTL
-Parthenolide is a natural compound used to treat migraines and arthritis and found to act as a potent NF-κB signaling inhibitor.

Main activities include:
-Inhibition of NF-κB Signaling:
-Induction of Oxidative Stress (ROS): oxidative stress can overwhelm the antioxidant defenses of the cancer cells, leading to cellular damage and death
-Parthenolide can interfere with STAT3 signaling, inhibiting the transcription of genes that favor tumor growth and resistance to apoptosis.
-Modulation of the MAPK/ERK Pathway:
-Impact on the JNK Pathway:
-Parthenolide has been shown to target cancer stem cells
Scientific Papers found: Click to Expand⟱
1983- Part,    Targeting thioredoxin reductase by micheliolide contributes to radiosensitizing and inducing apoptosis of HeLa cells
- in-vitro, Cerv, HeLa
"highlight2" >eff↑, "highlight2" >TrxR↓, "highlight2" >ROS↑, "highlight2" >RadioS↑,
1984- Part,    Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells
- in-vitro, Cerv, HeLa
"highlight2" >AntiCan↑, "highlight2" >TrxR1↓, "highlight2" >TrxR2↓, "highlight2" >ROS↑, "highlight2" >Apoptosis↑, "highlight2" >eff↓, "highlight2" >eff↑,
1985- Part,    KEAP1 Is a Redox Sensitive Target That Arbitrates the Opposing Radiosensitive Effects of Parthenolide in Normal and Cancer Cells
- in-vitro, Pca, LNCaP - in-vitro, Pca, DU145 - in-vitro, Nor, PrEC - in-vivo, NA, NA
"highlight2" >ROS↑, "highlight2" >NADPH↑, "highlight2" >RadioS↑, "highlight2" >radioP↑, "highlight2" >Trx↓, "highlight2" >*ox-Keap1↑, "highlight2" >ox-Keap1↓, "highlight2" >rd-Keap1↑, "highlight2" >*NRF2↑, "highlight2" >NRF2∅, "highlight2" >NF-kB↓,
1986- Part,    Modulation of Cell Surface Protein Free Thiols: A Potential Novel Mechanism of Action of the Sesquiterpene Lactone Parthenolide
- in-vitro, NA, NA
"highlight2" >JNK↑, "highlight2" >ROS↑, "highlight2" >eff↓, "highlight2" >NF-kB↓, "highlight2" >Trx↓,
1987- Part,  Rad,    A NADPH oxidase dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells
- in-vitro, Pca, PC3 - in-vitro, Nor, PrEC
"highlight2" >selectivity↑, "highlight2" >RadioS↑, "highlight2" >ROS↑, "highlight2" >*ROS∅, "highlight2" >NADPH↑, "highlight2" >Trx↓, "highlight2" >PI3K↑, "highlight2" >Akt↑, "highlight2" >p‑FOXO3↓, "highlight2" >SOD2↓, "highlight2" >Catalase↓, "highlight2" >radioP↑, "highlight2" >*NADPH∅, "highlight2" >*GSH↑, "highlight2" >*GSH/GSSG↑, "highlight2" >*NRF2↑,
1988- Part,    Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
- in-vitro, lymphoma, NCI-H929
"highlight2" >NF-kB↓, "highlight2" >ROS↑, "highlight2" >GSH↓, "highlight2" >MMP↓, "highlight2" >GPx1↓,
1989- Part,    Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties
- Review, Var, NA
"highlight2" >eff↑, "highlight2" >NF-kB↓, "highlight2" >STAT↓, "highlight2" >ROS↑, "highlight2" >Inflam↓, "highlight2" >Wnt↓, "highlight2" >TCF-4↓, "highlight2" >LEF1↓, "highlight2" >GSH↓, "highlight2" >MMP↓, "highlight2" >Casp↑, "highlight2" >eff↓, "highlight2" >CSCs↓,
1990- Part,    Parthenolide alleviates cognitive dysfunction and neurotoxicity via regulation of AMPK/GSK3β(Ser9)/Nrf2 signaling pathway
- in-vitro, AD, PC12
"highlight2" >*Apoptosis↓, "highlight2" >*ROS↓, "highlight2" >*MMP↓, "highlight2" >*memory↑, "highlight2" >*eff↑,
1991- Part,    A novel SLC25A1 inhibitor, parthenolide, suppresses the growth and stemness of liver cancer stem cells with metabolic vulnerability
- in-vitro, Liver, HUH7
"highlight2" >TumCCA↑, "highlight2" >Apoptosis↑, "highlight2" >CSCs↓, "highlight2" >ROS↑, "highlight2" >OXPHOS↓, "highlight2" >MMP↓, "highlight2" >SLC25A1↓, "highlight2" >IDH2↓,
1992- Part,    Parthenolide induces ROS-dependent cell death in human gastric cancer cell
- in-vitro, BC, MGC803
"highlight2" >TumCCA↑, "highlight2" >Casp↑, "highlight2" >Apoptosis↑, "highlight2" >Necroptosis↑, "highlight2" >RIP1↓, "highlight2" >RIP3↑, "highlight2" >MLKL↑, "highlight2" >ROS↑, "highlight2" >eff↓,
1993- Part,    Parthenolide induces apoptosis and autophagy through the suppression of PI3K/Akt signaling pathway in cervical cancer
- in-vitro, Cerv, HeLa
"highlight2" >tumCV↓, "highlight2" >TumAuto↑, "highlight2" >Casp3↑, "highlight2" >BAX↑, "highlight2" >Beclin-1↑, "highlight2" >ATG3↑, "highlight2" >ATG5↑, "highlight2" >Bcl-2↓, "highlight2" >mTOR↓, "highlight2" >PI3K↓, "highlight2" >Akt↓, "highlight2" >PTEN↑, "highlight2" >ROS↑, "highlight2" >MMP↓,
1994- Part,    Parthenolide Inhibits Tumor Cell Growth and Metastasis in Melanoma A2058 Cells
- in-vitro, Melanoma, A2058 - in-vitro, Nor, L929
"highlight2" >tumCV↓, "highlight2" >selectivity?, "highlight2" >ROS?, "highlight2" >BAX↑, "highlight2" >TumCCA?, "highlight2" >MMP2↓, "highlight2" >MMP9↓, "highlight2" >TumCMig↓, "highlight2" >eff↑,
1995- Part,    The protective effect of parthenolide in an in vitro model of Parkinson's disease through its regulation of nuclear factor-kappa B and oxidative stress
- in-vitro, Park, SH-SY5Y
"highlight2" >*Apoptosis↓, "highlight2" >*ROS↓, "highlight2" >*BAX↓, "highlight2" >*NF-kB↓, "highlight2" >*P53↓, "highlight2" >*p‑NF-kB↓,
1996- Part,    Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells
- in-vitro, CRC, COLO205
"highlight2" >Apoptosis↑, "highlight2" >GSH↓, "highlight2" >ROS↑, "highlight2" >Ca+2↑, "highlight2" >GRP78/BiP↑, "highlight2" >ER Stress↑, "highlight2" >eff↓, "highlight2" >eff↑, "highlight2" >Thiols↓,

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 14

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

Catalase↓, 1,   GPx1↓, 1,   GSH↓, 3,   ox-Keap1↓, 1,   rd-Keap1↑, 1,   NRF2∅, 1,   OXPHOS↓, 1,   ROS?, 1,   ROS↑, 11,   SOD2↓, 1,   Thiols↓, 1,   Trx↓, 3,   TrxR↓, 1,   TrxR1↓, 1,   TrxR2↓, 1,  

Mitochondria & Bioenergetics ⓘ

MMP↓, 4,  

Core Metabolism/Glycolysis ⓘ

IDH2↓, 1,   NADPH↑, 2,   SLC25A1↓, 1,  

Cell Death ⓘ

Akt↓, 1,   Akt↑, 1,   Apoptosis↑, 4,   BAX↑, 2,   Bcl-2↓, 1,   Casp↑, 2,   Casp3↑, 1,   JNK↑, 1,   MLKL↑, 1,   Necroptosis↑, 1,   RIP1↓, 1,  

Transcription & Epigenetics ⓘ

tumCV↓, 2,  

Protein Folding & ER Stress ⓘ

ER Stress↑, 1,   GRP78/BiP↑, 1,  

Autophagy & Lysosomes ⓘ

ATG3↑, 1,   ATG5↑, 1,   Beclin-1↑, 1,   TumAuto↑, 1,  

Cell Cycle & Senescence ⓘ

TumCCA?, 1,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State ⓘ

CSCs↓, 2,   p‑FOXO3↓, 1,   mTOR↓, 1,   PI3K↓, 1,   PI3K↑, 1,   PTEN↑, 1,   STAT↓, 1,   TCF-4↓, 1,   Wnt↓, 1,  

Migration ⓘ

Ca+2↑, 1,   LEF1↓, 1,   MMP2↓, 1,   MMP9↓, 1,   RIP3↑, 1,   TumCMig↓, 1,  

Immune & Inflammatory Signaling ⓘ

Inflam↓, 1,   NF-kB↓, 4,  

Drug Metabolism & Resistance ⓘ

eff↓, 5,   eff↑, 5,   RadioS↑, 3,   selectivity?, 1,   selectivity↑, 1,  

Functional Outcomes ⓘ

AntiCan↑, 1,   radioP↑, 2,  
Total Targets: 63

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

GSH↑, 1,   GSH/GSSG↑, 1,   ox-Keap1↑, 1,   NRF2↑, 2,   ROS↓, 2,   ROS∅, 1,  

Mitochondria & Bioenergetics ⓘ

MMP↓, 1,  

Core Metabolism/Glycolysis ⓘ

NADPH∅, 1,  

Cell Death ⓘ

Apoptosis↓, 2,   BAX↓, 1,  

DNA Damage & Repair ⓘ

P53↓, 1,  

Immune & Inflammatory Signaling ⓘ

NF-kB↓, 1,   p‑NF-kB↓, 1,  

Drug Metabolism & Resistance ⓘ

eff↑, 1,  

Functional Outcomes ⓘ

memory↑, 1,  
Total Targets: 15

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:8  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page